Navigation Links
CEL-SCI Hires Vice President of Manufacturing/Facilities and Commercial Operations
Date:1/15/2010

VIENNA, Va., Jan. 15 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE CVM), a late-stage oncology company and a developer of vaccines and therapeutics for the treatment of infectious diseases, announced today the appointment of Todd S. Burkhart as Vice President of Manufacturing/Facilities and Commercial Operations for its manufacturing facility.  Mr. Burkhart has over 30 years of experience in the manufacture and process development of biologicals, medical devices and other Active Pharmaceutical Ingredients (APIs).  During his distinguished  career in the Pharmaceutical and Biopharmaceutical Industry and prior to joining CEL-SCI, Mr. Burkhart has been responsible for all aspects of GMP manufacturing and operations, including production, materials controls and facilities maintenance.  In addition he has extensive experience in the design of manufacturing facilities meeting FDA GMP requirements.  Mr. Burkhart has also been involved in the building and/or running a number of major pharmaceutical facilities at companies such as Cephalon, Human Genome Sciences and Univax Biologics.

Geert Kersten, Chief Executive Officer of CEL-SCI, said:  "We are pleased to have been able to attract to our team such an accomplished executive, with deep experience and expertise in all facets of the manufacturing process for biologics and other drugs. This hire represents another step CEL-SCI has taken in order to increase the likelihood of a successful outcome of its global pivotal Phase III study of Multikine® for the treatment of head and neck cancer."

About CEL-SCI Corporation

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product Multikine is being readied for a global pivotal Phase III clinical trial in advanced pr
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine
2. CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine
3. CEL-SCI Corporation Releases Letter to Shareholders
4. CEL-SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1-Infected Patients
5. CEL-SCI Expands H1N1 Flu Virus Work
6. CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
7. CEL-SCI Posts New Corporate Presentation to Website
8. CEL-SCI Corporation Releases Letter to Shareholders
9. CEL-SCI Corporation Releases Letter to Shareholders
10. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
11. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015  Celsion Corporation ... the Company will host a conference call to ... update on its development programs for ThermoDox®, its ... newly acquired technology platforms, TheraPlas™ and TheraSilence™, in ... on Thursday, March 12, 2015. To participate in ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4q7gwz/india_pharma ) has ... 2015: Accelerating growth to the next level - Moving ... their offering. Domestic sales improved in ... by the market,s reaction to the new drug pricing ... be healthy, as the momentum continues and improving economic ...
(Date:3/5/2015)... DUBLIN and HAMPTON, N.J. ... (NYSE: MNK ), a leading global ... care company, announced today that they have entered into ... will acquire Ikaria, Inc. from a Madison Dearborn ... $2.3 billion. Subject to customary closing ...
Breaking Medicine Technology:Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9
... Sept. 15, 2011 Inogen has won a service ... and devices to patients in TRICARE,s 21-state western service ... the Inogen One portable oxygen concentrator to ... TRICARE West (TriWest) covers 2.7 million patients in ...
... N.J., Sept. 15, 2011 Fidia Farmaceutici S.p.A. (Fidia) ... (sodium hyaluronate), an injectable treatment for knee pain ... physical therapy are not enough, will be transferred from ... 2011.  Fidia Farmaceutici S.p.A. is the owner and manufacturer ...
Cached Medicine Technology:Inogen Awarded Contract to Service TRICARE West Oxygen Therapy Patients 2HYALGAN® (sodium hyaluronate) Commercial Rights Transfer Back to Fidia Farmaceutici S.p.A. 2
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market ... 7.8% from 2014 to 2019. , The global digital PCR (dPCR) ... 7.8% from 2014 to 2019. Although the mature markets such as ... digital PCR (dPCR) and qPCR market the Asia-Pacific region is expected ... period. The growth of the digital PCR (dPCR) and qPCR market ...
(Date:3/5/2015)... 05, 2015 Risperdal lawsuits ( ... Pennsylvania mass tort litigation currently underway in the ... has begun hearing testimony in the proceeding’s second ... medication can cause gynecomastia, or male breast growth. ... was filed on behalf of a plaintiff who ...
(Date:3/5/2015)... The Maricopa Community Colleges add $7.3 ... economy each year, according to a research report released ... Maricopa County Community College District, summarizes economic impact and ... year 2013-2014. , The analysis was conducted by ... that specializes in providing economic impact studies and labor ...
(Date:3/5/2015)... At the 7th Annual Mississippi Addiction Conference ... met today in Jackson, Mississippi to listen to keynote ... numerous respected speakers will be William S. Jacobs, ... pain medications have had in today’s opiate overdose and ... is hard to believe that much of the current ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Taking ... in Fort Worth, Texas April 9-11th is IDRevolution ... company providing personalized nutrition. IDLife offers a ... IDNutrition. This customized approach to vitamin supplementation ... begins with a free HIPAA compliant online assessment ...
Breaking Medicine News(10 mins):Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2
... explanations, study finds , TUESDAY, March 30 (HealthDay News) -- ... trials, most do not receive a clear explanation of their ... report suggests. , In the study, U.S. researchers interviewed 37 ... that more than half of them did not know or ...
... benefit more if they sought advice from doctors, pharmacists, study ... person with knee pain who learns that the cause is ... do the right things to treat it, and probably won,t ... , "Most of the things they did were appropriate," said ...
... ... ... -- Those with aching backs might want to look at their home décor to help ... price range, but many don,t take time to consider products that can actually benefit their ...
... ... ... media company for people who want to live well and do good, today announced three ... YouTube), Jill Beraud (Chief Marketing Officer of Pepsi Americas Beverages & President, Joint Ventures) and ...
... ... , ... 30, 2010 -- Tahitian Noni International (TNI) announced that their 2011 International ... of the Seas, one of the most luxurious cruise ships in the world. The announcement ...
... ... brought over 35 years of experience in industrial fabricating to the medical field. Midbrook ... tables, as well as cleaning and decontamination equipment. , ... (Vocus) March 30, 2010 -- Midbrook, the Jackson, ...
Cached Medicine News:Health News:Many Kids Not Fully Informed of Their Role in Cancer Studies 2Health News:Many With Arthritis Find Simple Solutions for Relief 2Health News:Proper Home Dcor May Assist in Alleviating Back Pain 2Health News:Proper Home Dcor May Assist in Alleviating Back Pain 3Health News:GOOD Adds Depth to Advisory Board 2Health News:Caribbean Cruise Announced by Tahitian Noni International for 2011 2Health News:Midbrook Medical Brings Industrial Experience to Medical Fabrication 2Health News:Midbrook Medical Brings Industrial Experience to Medical Fabrication 3
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German ... finest surgical instrumentation in ... makes them available to ... the coveted Meisterbrief certificate, ...
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest....
... the most comprehensive family of lightweight ... Cataract incision, Glaucoma filtration, and Vitreoretinal ... achieved with minimal tissue trauma and ... styles are available in 18, 20, ...
Medicine Products: